The present study investigated the effects of asprosin on the transcriptome of the BeWo and JEG-3 p2lacental cell lines, and assessed the expression of FBN1/Furin and asprosin's candidate receptors in healthy placentas when compared against placentas from pregnancies where the carrier had gestational diabetes mellitus (GDM). This evidence concerns the gene FBN1 and gestational diabetes.